Fanney Thorsteinsdottir

Dr. Fanney Thorsteinsdottir

Parker Instituttet
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2022 in Calcified Tissue International
Verified
Journal Article
Closed access
PDF file
CMCaterina Mosca
Caterina Mosca
FTFanney Thorsteinsdottir
Fanney Thorsteinsdottir
BABo Abrahamsen
Bo Abrahamsen
JRJüri Johannes Rumessen
Jüri Johannes Rumessen
Mina HändelMina Händel
Mina Händel

21 March 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
FTFanney Thorsteinsdottir
Fanney Thorsteinsdottir
ICIsabel Cardoso
Isabel Cardoso
AKAmelie Keller
Amelie Keller
MSMaria Stougaard
Maria Stougaard
PFPeder Frederiksen
Peder Frederiksen
BHBerit Lilienthal Heitmann
Berit Lilienthal Heitmann
Background: low vitamin D status in pregnancy can influence the offspring’s lung function and contribute to childhood asthma development. The objective of this study was to examine the influence of neonatal vitamin D status on the development of asthma among children age 3–9 years in a large population sample. Method: in a case-cohort study utilizing a Danish biobank and register data we examined the association between neonatal 25-hydroxyvitamin D3 (25(OH)D3) concentrations and incidence of asthma among children aged 3–9 years. Cases of asthma (n = 911) were randomly selected among all cases of asthma in the Danish National Patient Register from children born between 1992 and 2002. The sub-cohort (n = 1423) was randomly selected among all children born in the same period. We used a weighted Cox proportional hazard model assessing the hazard of first asthma diagnoses by quintiles of 25(OH)D3. Results: the median 25(OH)D3 (interquartile range) for asthma cases was 23 nmol/L (14–35) and the sub-cohort 25 nmol/L (14–40). The hazard ratio for developing asthma between ages 3 and 9 years was lower for children in the fifth quintile of neonatal 25(OH)D3 compared to children in the first quintile, both in the unadjusted (0.61 95% CI: 0.46–0.80) and adjusted (0.55 95% CI: 0.39–0.77) analyses. Conclusion: the results from our study suggest that higher neonatal vitamin D concentration may reduce the risk of developing childhood asthma at ages 3–9 years, indicating that neonatal vitamin D status as a proxy of vitamin D status during the prenatal period is important for normal immune- and lung development.

ICIsabel Cardoso
Isabel Cardoso
PFPeder Frederiksen
Peder Frederiksen
ISIna Olmer Specht
Ina Olmer Specht
Mina HändelMina Händel
Mina Händel
FTFanney Thorsteinsdottir
Fanney Thorsteinsdottir
LKLars Erik Kristensen
Lars Erik Kristensen
This study reports age- and sex-specific incidence rates of juvenile idiopathic arthritis (JIA) in complete Danish birth cohorts from 1992 through 2002. Data were obtained from the Danish registries. All persons born in Denmark, from 1992–2002, were followed from birth and until either the date of first diagnosis recording, death, emigration, 16th birthday or administrative censoring (17 May 2017), whichever came first. The number of incident JIA cases and its incidence rate (per 100,000 person-years) were calculated within sex and age group for each of the birth cohorts. A multiplicative Poisson regression model was used to analyze the variation in the incidence rates by age and year of birth for boys and girls separately. The overall incidence of JIA was 24.1 (23.6–24.5) per 100,000 person-years. The rate per 100,000 person-years was higher among girls (29.9 (29.2–30.7)) than among boys (18.5 (18.0–19.1)). There were no evident peaks for any age group at diagnosis for boys but for girls two small peaks appeared at ages 0–5 years and 12–15 years. This study showed that the incidence rates of JIA in Denmark were higher for girls than for boys and remained stable over the observed period for both sexes.

5 July 2019 in European Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
ISIna Olmer Specht
Ina Olmer Specht
JJJanet Janbek
Janet Janbek
FTFanney Thorsteinsdottir
Fanney Thorsteinsdottir
PFPeder Frederiksen
Peder Frederiksen
BHBerit Lilienthal Heitmann
Berit Lilienthal Heitmann

17 September 2024 in Current Obesity Reports
Verified
Journal Article
Open access
PDF file
BHBerit Lilienthal Heitmann
Berit Lilienthal Heitmann
RKRasmus Køster-Rasmussen
Rasmus Køster-Rasmussen
LMLene B. Meyer
Lene B. Meyer
SLSofus C. Larsen
Sofus C. Larsen
FTFanney Thorsteinsdottir
Fanney Thorsteinsdottir
CDCarsten Dirksen
Carsten Dirksen
Purpose of Review Despite decades of development and testing of weight-loss interventions, the adult populations worldwide have witnessed a continuous rise in body weight. There is an ongoing debate about how to move forward. Some argue that this rise calls for more intensive and possibly life-long treatments, including the new effective GLP1 weight loss medications, while others have called for a fundamental shift away from weight and on to a broader understanding of health. The two strategies are represented as a weight-centric health strategy and a weight neutral health strategy. This paper debates the benefits and potential harms related to the use of these two strategies. Recent Findings While major weight loss may have substantial health benefits, many individuals will need intensive treatment including weight loss medication to achieve it, as generally few are able to sustain a lifestyle induced weight loss in the long term. Summary Both the weight loss and the weight-neutral health strategies have advantages and limitations emphasizing the need for further research comparing the two strategies. Currently, not everyone is offered, can afford, will tolerate or even desire treatment with weight loss medication, and weight neutral health strategies may be a desirable alternative intervention offering a more holistic approach to health and addressing psychological and social issues including the burden of experienced and internalized weight stigma. However, this method still needs to be tested for effectiveness with regards to both physical and long-term psychological benefits.

4 May 2020 in Epilepsia
Verified
Journal Article
Closed access
PDF file
ISIna Olmer Specht
Ina Olmer Specht
FTFanney Thorsteinsdottir
Fanney Thorsteinsdottir
KWKaren Christina Walker
Karen Christina Walker
JOJørn Olsen
Jørn Olsen
BHBerit Lilienthal Heitmann
Berit Lilienthal Heitmann